Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
McKesson
Boehringer Ingelheim
Baxter
Cipla
US Department of Justice
Argus Health
Accenture
Queensland Health

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,648,379

« Back to Dashboard

Summary for Patent: 5,648,379
Title: Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
Abstract:Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation and their use in the treatment of viral infections, in particular influenza, are described.
Inventor(s): Von Itzstein; Laurence Mark (North Fitzroy, AU), Wu; Wen-Yang (Mount Waverley, AU), Van Phan; Tho (Carnegie, AU), Danylec; Basil (Box Hill, AU), Jin; Betty (Mount Waverly, AU), Colman; Peter Malcolm (East Melbourne, AU), Varghese; Joseph Noozhumurry (Brunswick, AU)
Assignee: Biota Scientific Management Pty., Ltd. (Melbourne, AU)
Application Number:08/325,074
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation; Use;

Drugs Protected by US Patent 5,648,379

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,648,379

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPJ 9800Apr 24, 1990
AustraliaPK 2896Oct 19, 1990
AustraliaPK 4537Feb 11, 1991

International Patents Family Members for US Patent 5,648,379

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1036849 ➤ Try a Free Trial
China 1150020 ➤ Try a Free Trial
China 1091594 ➤ Try a Free Trial
China 1184108 ➤ Try a Free Trial
China 1143853 ➤ Try a Free Trial
Czechoslovakia 9101145 ➤ Try a Free Trial
Croatia P930455 ➤ Try a Free Trial
Cyprus 2186 ➤ Try a Free Trial
Czech Republic 288492 ➤ Try a Free Trial
Hong Kong 1010191 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Merck
Baxter
Healthtrust
Mallinckrodt
Daiichi Sankyo
Express Scripts
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot